You are here: Industry Insights > mRNA vaccine

News List

Experts Demand That Biden Do More to Distribute COVID-19 Vaccines Globally drugs
August 12, 2021
More than 175 public health experts, scientists, and activists on Tuesday called for President Joe Biden to do more to help fight the global spread of COVID-19, warning that newer, more dangerous variants are likely to emerge if nothing is done.
Moderna to build mRNA vaccine manufacturing facility in Canada cphi-online
August 12, 2021
The new facility will provide access to domestically manufactured vaccines against respiratory viruses
Multiple Myeloma Patients Display Weakened Antibody Responses to mRNA COVID Vaccines firstwordpharma
August 02, 2021
A new study reports weakened antibody responses to COVID-19 mRNA vaccines among most patients with multiple myeloma, a common form of bone-marrow cancer associated with an immunocompromised state.
Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose firstwordpharma
July 28, 2021
In a multi-hospital analysis of individuals who experienced an allergic reaction to their first mRNA COVID-19 vaccine dose, all patients who went on to receive a second dose tolerated it without complications.
Take your best shot: Which SARS-CoV-2 vaccine should I get, if any? worldpharmanews
July 22, 2021
Vaccine hesitancy continues to be a hurdle in the development of widespread immunity within the U.S. population as the COVID-19 pandemic enters its second year.
Startups join CSL, Moderna in local mRNA vaccine manufacturing push firstwordpharma
July 22, 2021
Australian biotech startups and small businesses have joined pharmaceutical majors like CSL in pitching to the federal government for a role in making mRNA products in the country, reported The Age.
Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist firstwordpharma
July 12, 2021
Viral vector and mRNA vaccines, including Russia's Sputnik V, provide enough protection against the new Delta strain of the coronavirus, albeit to a lesser extent, reported The Times of India.
First people dosed with a quadrivalent seasonal flu mRNA vaccine europeanpharmaceuticalreview
July 09, 2021
The Phase I/II trial will assess the safety, reactogenicity and immunogenicity of Moderna’s mRNA-1010 seasonal flu vaccine.
Ignite Life Science Foundation announces grant for developing mRNA vaccine technology expresspharma
July 06, 2021
A grant of three years was awarded to the Indian Institute of Science (Bangalore) and the Translational Health Science and Technology Institute (Faridabad).
COVID-19 mRNA vaccine technology transfer hub to be set up in South Africa europeanpharmaceuticalreview
June 23, 2021
A South African consortium will be the first to establish a COVID-19 mRNA vaccine technology transfer hub to scale up vaccine production and access.

Previous page 1 2 3 4 5 Next page